Sign in

CIK 0001868279 · Non-accelerated filer<br>Emerging growth company

ArriVent BioPharma, Inc.

Sign in to watch
Ticker
AVBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
240-780-6356
Business address
18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
  1. 8-K Event Bylaws or fiscal year change · Other events
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  5. 424B4 Offering Prospectus
  6. EFFECT Other Notice of Effectiveness
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. S-1MEF Other S-1MEF
  19. CERT Other Certification
  20. S-1/A Offering Registration Statement

Page 7 of 9 · 162 filings